Toggle navigation
Home
Search
Services
Blog
Contact
About
Develop Emulsified Lipoid Contrast Media
Chatterji, Dulal
Quad Pharmaceuticals, Indianapolis, IN, United States
Search grants from Dulal Chatterji
Search grants from Quad Pharmaceuticals
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Correlative efficacy, biomarker, and mechanistic studies associated with a phase Ib/II clinical trial of treating mCRPC patients with enzalutamide and Venetoclax
R-Ras signaling in vascular biology
Chromatin Structure during Spermatogenesis
Cryopreservation of Sperm
Recently added grants:
The Evolution of PGD addiction in Human Pancreatic Cancer
Child Health Research Career Development Award (CHRCDA) Program (K12)
Treatment of Mal de Debarquement Syndrome (MdDS) by habituation of Velocity Storage.
White Matter Toxicity and Neurocognitive Outcomes in Pediatric Brain Tumor Patients Treated with Proton Beam Radiation Therapy
Predicting Transcriptional and Epigenetic Networks in Cancer from Sequencing Data
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
Division of Cancer Treatment (NCI)
Type
Small Business Innovation Research – Phase I (N43)
Project #
N43CM067953-000
Application #
3614596
Study Section
Project Start
1986-09-30
Project End
Budget Start
1986-09-30
Budget End
1987-03-30
Support Year
Fiscal Year
1986
Total Cost
Indirect Cost
Institution
Name
Quad Pharmaceuticals
Department
Type
DUNS #
City
Indianapolis
State
IN
Country
United States
Zip Code
46268
Related projects
NIH 1987
N43 CM
Develop Emulsified Lipoid Contrast Media
Chatterji, Dulal / Quad Pharmaceuticals
NIH 1986
N43 CM
Develop Emulsified Lipoid Contrast Media
Chatterji, Dulal / Quad Pharmaceuticals
Comments
Be the first to comment on Dulal Chatterji's grant